Clicky

PDS Biotechnology Corporation(PDSB) News

Date Title
Mar 13 The 3 Most Undervalued Biotech Stocks to Buy in March 2024
Mar 13 PDS Biotech Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Patent for Infectimune®
Jan 16 PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference
Jan 2 All You Need to Know About PDS Biotechnology (PDSB) Rating Upgrade to Buy
Dec 4 PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov 28 PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
Sep 6 PDS Biotech to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
Sep 6 PDS0202 Universal Influenza Preclinical Ferret Data to be Presented in Oral Lecture at 9th ESWI Conference
Aug 7 PDS Biotechnology Announces Conference Call and Webcast for Second Quarter 2023 Financial Results
May 25 PDS Biotech Announces Interim Data Demonstrates 12-Month Survival Rate of 87% with PDS0101 in Combination with KEYTRUDA® (pembrolizumab) for Head and Neck Cancer Patients